In the Nordic pharmaceutical market, growth was modest during February–July 2009. The strong growth in Denmark (7.2%) resulted from substantial deliveries to hospitals and does not represent the development in private pharmacies.
In the Baltic region, the economic slowdown strongly impacted consumer demand, leading also to a decline in pharmaceutical sales.
In Poland, the steady pharmaceutical market growth continued during the second quarter.